AMRX Jun 2024 5.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:42AM EDT. Market open.
| Previous close | 1.8100 |
| Open | 1.8100 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 5.00 |
| Expiry date | 2024-06-21 |
| Day's range | 1.8100 - 1.8100 |
| Contract range | N/A |
| Volume | |
| Open interest | 206 |
GuruFocus.comInsider Sale: Director Deborah Autor Sells 38,000 Shares of Amneal Pharmaceuticals Inc (AMRX)
On May 17, 2024, Deborah Autor, Director at Amneal Pharmaceuticals Inc (NASDAQ:AMRX), executed a sale of 38,000 shares of the company.
Simply Wall St.Amneal Pharmaceuticals First Quarter 2024 Earnings: US$0.30 loss per share (vs US$0.046 loss in 1Q 2023)
Amneal Pharmaceuticals ( NASDAQ:AMRX ) First Quarter 2024 Results Key Financial Results Revenue: US$659.2m (up 18% from...
- GuruFocus.com
Amneal Pharmaceuticals Inc (AMRX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
Amneal Pharmaceuticals reports significant revenue and EBITDA growth in Q1 2024, driven by new product launches and strong market performance.
© 2024 Yahoo. All rights reserved.